T-wave Alternans and Intrathoracic Impedance Measurements
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/21/2012 |
| Start Date: | August 2008 |
| End Date: | March 2012 |
| Contact: | Jose M Dizon, MD |
| Email: | jmd11@columbia.edu |
| Phone: | 212-305-8559 |
T-wave alternans is a test that is currently being used to risk stratify patients with
structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is
unclear, but may share a common abnormality with conditions of cardiac fluid overload such
as heart failure, which is altered intracellular calcium handling. Current Medtronic
implantable defibrillators have the capability of monitoring cardiac fluid status via
transthoracic impedance measurements.
The purpose of this study is to determine if a correlation exists between T-wave alternans
status and cardiac volume status, as determined by transthoracic impedance measurements.
Secondarily, the study seeks to examine the relationship between arrhythmia frequency and
T-wave alternans or cardiac volume status.
Inclusion Criteria:
- Class III or IV heart failure patients with a chronically implanted Medtronic
biventricular defibrillator system capable of monitoring intrathoracic fluid volume.
Exclusion Criteria:
- no active ischemia or pulmonary edema, atrial fibrillation, complete heart block
We found this trial at
1
site
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
